These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6383521)

  • 41. Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels.
    Williams JH; Miall-Allen VM; Klinowski M; Azmitia EC
    Neuroendocrinology; 1983 Jun; 36(6):431-5. PubMed ID: 6877522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serotonin neurotoxins: recent advances in the mode of administration and molecular mechanism of action.
    Baumgarten HG; Jenner S; Klemm HP
    J Physiol (Paris); 1981; 77(2-3):309-14. PubMed ID: 7288647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of hypothalamic serotonin depletion on lordosis behavior and gonadal hormone receptors.
    Luine VN; Thornton JE; Frankfurt M; MacLusky NJ
    Brain Res; 1987 Nov; 426(1):47-54. PubMed ID: 3690318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
    Minnema DJ; Rosecrans JA
    Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intraventricular 5,7-dihydroxytryptamine increases thyrotropin-releasing hormone content in regions of rat brain.
    Manaker S; Engber TM; Knight PB; Winokur A
    J Neurochem; 1985 Oct; 45(4):1315-8. PubMed ID: 3928818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
    Vergnes M; Penot C; Kempf E; Mack G
    Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
    [No Abstract]   [Full Text] [Related]  

  • 47. Regional central serotonin-2 receptor binding and phosphoinositide turnover in rats with 5,7-dihydroxytryptamine lesions.
    Butler PD; Pranzatelli MR; Barkai AI
    Brain Res Bull; 1990 Jan; 24(1):125-9. PubMed ID: 2155684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tail temperature in rats after intraventricular injections of 6-hydroxydopamine or 5,7-dihydroxytryptamine.
    Ishikawa Y; Matuszek M; Nakayama T
    Neurosci Lett; 1980 Nov; 20(2):177-81. PubMed ID: 7443067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of intracerebral injections of 5,7-dihydroxytryptamine and 6-hydroxydopamine on the serotonin-immunoreactive cell bodies and fibers in the adult rat hypothalamus.
    Frankfurt M; Azmitia E
    Brain Res; 1983 Feb; 261(1):91-9. PubMed ID: 6404500
    [No Abstract]   [Full Text] [Related]  

  • 50. Reduction of substance P levels in the ventral cervical spinal cord of the rat after intracisternal 5,7-dihydroxytryptamine injection.
    Singer E; Sperk G; Placheta P; Leeman SE
    Brain Res; 1979 Oct; 174(2):362-5. PubMed ID: 487135
    [No Abstract]   [Full Text] [Related]  

  • 51. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 52. Regeneration of normal terminal innervation patterns by central noradrenergic neurons after 5,7-dihydroxytryptamine-induced axotomy in the adult rat.
    Björklund A; Lindvall O
    Brain Res; 1979 Aug; 171(2):271-93. PubMed ID: 466444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of indolic neurotoxins on enteric serotonergic neurons.
    Gershon MD; Sherman DL; Dreyfus CF
    J Comp Neurol; 1980 Apr; 190(3):581-96. PubMed ID: 7391271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of intracerebroventricular 5,7-dihydroxytryptamine on morphine analgesia is time-dependent.
    Romandini S; Pich EM; Esposito E; Kruszewska AZ; Samanin R
    Life Sci; 1986 Mar; 38(10):869-75. PubMed ID: 3951313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
    Kirby ML; Mattio TG
    Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of body weight changes after selective serotonin depletion with 5,7-dihydroxytryptamine.
    Baez LA; Browning RA; Cusatis M
    Prog Neuropsychopharmacol; 1980; 4(2):123-7. PubMed ID: 7403347
    [No Abstract]   [Full Text] [Related]  

  • 58. The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.
    Commissaris RL; Mokler DJ; Lyness WH; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1981 Jun; 14(6):915-8. PubMed ID: 6973157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
    Mueller RA; Towle A; Breese GR
    Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of intracisternal 5,-7-dihydroxytryptamine on the acute antihypertensive action of propranolol in the sino-aortic denervated anaesthetized dog.
    Montastruc JL; Montastruc P
    Br J Pharmacol; 1981 Mar; 72(3):411-7. PubMed ID: 7260484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.